Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesVaccination With Agonist Peptide PSA: 154-163 (155L) Derived From Prostate Specific Antigen Induced CD8 T-Cell Response to the Native Peptide PSA: 154-163 But Failed to Induce the Reactivity Against Tumor Targets Expressing PSA: A Phase 2 Study in Patients With Recurrent Prostate Cancer
Journal of Immunotherapy, 06/24/09
Kouiavskaia DV et al. - There were no significant changes in serum PSA level in any subject. No serious adverse events were observed. PSA: 154-163 is not an effective immunogen when given with Montanide ISA-51. The PSA: 154-163 peptide is poorly processed from endogenous PSA and therefore represents a cryptic epitope of PSA in HLA-A2 antigen-presenting cells.
Related Articles
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 72%
Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4 + 3 and Gleason 3 + 4 Tumors in a Population Based Cohort
The Journal of Urology, 11/20/09
Relevance Score: 71%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 71%
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09
Relevance Score: 71%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 71%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutiny on the Boun-T: Controlling Dangerous T Cells Through Anergy
Discovery Medicine, 12/17/09
Immunolocalization and mRNA Expression of Bone Morphogenetic Protein-6 in Human Clear Cell Renal Carcinoma
Kidney and Blood Pressure Research, 12/17/09
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Breast Cancer Research and Treatment, 12/17/09
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunolocalization and mRNA Expression of Bone Morphogenetic Protein-6 in Human Clear Cell Renal Carcinoma
Kidney and Blood Pressure Research, 12/17/09
Kidney Transplantation in Patients With HIV Infection
Advances In Chronic Kidney Disease , 12/17/09
A Randomized and Prospective Study Comparing Treatment With High-Dose Intravenous Immunoglobulin With Monoclonal Antibodies for Rescue of Kidney Grafts With Steroid-Resistant Rejection
Transplantation, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor